GSK-3β inhibitor 14
This compound, a 1,5-benzothiazepin-4 (5H) -one derivative, acts as a weak inhibitor of GSK-3β with an IC50 exceeding 100 μM. It serves as a useful research tool for investigating GSK-3β signaling pathways in cellular models of neurological disorders and diabetes.
Product Specifications
CAS Number
863004-48-2
Product Name Alternative
1,5-Benzothiazepin-4 (5H) -one, 2,3-dihydro-2-methyl-5- (phenylmethyl) -, GSK-3β inhibitor 14, GSK-3β, GSK-3beta inhibitor 14, GSK-3b inhibitor 14, GSK3
Field of Research
Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:2.88 mg/mL (10.16 mM)
Smiles
C (N1C=2C (SC (C) CC1=O) =CC=CC2) C3=CC=CC=C3
Molecular Formula
C17H17NOS
Molecular Weight
283.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1777302 1.0 µg DNA
RAC1P4 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 